Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multaq for maintenance of sinus rhythm in AF/AFL (ADONIS)
NCT00259376Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2001
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of dronedarone in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Sanofi. Started Nov 2001; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT00259376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259376.